| Recruitment status | Completed |
| Unique ID issued by UMIN | UMIN000015274 |
| Receipt No. | R000017765 |
| Official scientific title of the study | Ultrasound-guided quadratus lumborum block for laparoscopic gynecological surgery :a randomized controlled trial |
| Date of disclosure of the study information | 2014/09/30 |
| Last modified on | 2016/07/26 (Ver. 7) |
| Basic information | ||
| Official scientific title of the study | Ultrasound-guided quadratus lumborum block for laparoscopic gynecological surgery :a randomized controlled trial | |
| Title of the study (Brief title) | Efficacy of ultrasound-guided quadratus lumborum block for laparoscopic gynecological surgery | |
| Region |
|
|
| Condition | ||||
| Condition | myometrium
adenomyosis of uterus gynecological benign tumor |
|||
| Classification by specialty |
|
|||
| Classification by malignancy | Others | |||
| Genomic information | NO | |||
| Objectives | |
| Narrative objectives1 | Ultrasound-guided quadratus lumborum block (USG-QLB) could be provided visceral analgesia due to sympathetic nerve block, but most suitable injection point is still unknown. We performed two different approaches of USG-QLB for gynecological laparoscopic surgery and examined their efficacy and quality of recovery. |
| Basic objectives2 | Efficacy |
| Basic objectives -Others | |
| Trial characteristics_1 | |
| Trial characteristics_2 | |
| Developmental phase | |
| Assessment | |
| Primary outcomes | postoperative fentanyl consumption
the Quality of Recovery-40 (QoR-40) questionnaire at 24h after surgery Visual analog scale at a cough |
| Key secondary outcomes | |
| In outcomes field, the entry of just a few words such as "safety" or "efficiency" will not be accepted. Specify the name of outcome measures, including the time when you plan to measure. Usually, only one primary outcome is accepted. Write the other outcomes in "secondary outcomes" field. |
| Base | |
| Study type | Interventional |
| Study design | |
| Basic design | Parallel |
| Randomization | Randomized |
| Randomization unit | Individual |
| Blinding | Open -but assessor(s) are blinded |
| Control | Active |
| Stratification | |
| Dynamic allocation | |
| Institution consideration | |
| Blocking | |
| Concealment | |
| Intervention | ||||
| No. of arms | 2 | |||
| Purpose of intervention | Treatment | |||
| Type of intervention |
|
|||
| Interventions/Control_1 | Drug injection point is posterior side of quadratus lumborum | |||
| Interventions/Control_2 | Drug injection point is antero-lateral side of quadratus lumborum | |||
| Interventions/Control_3 | ||||
| Interventions/Control_4 | ||||
| Interventions/Control_5 | ||||
| Interventions/Control_6 | ||||
| Interventions/Control_7 | ||||
| Interventions/Control_8 | ||||
| Interventions/Control_9 | ||||
| Interventions/Control_10 | ||||
| In interventions field, include the details of interventions, such as duration, amount, and frequency. If the intervention includes prescription or use of medical devices, duration is required. |
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Female | |||
| Key inclusion criteria | ASA-PS status 1 to 2 | |||
| Key exclusion criteria | Allergy to local anesthetics, coagulation disorders over 1.2 of PT-INR | |||
| Target sample size | 60 | |||
| Research contact person | |
| Name of lead principal investigator | Taro Fujitani |
| Organization | Ehime Prefectural Central Hospital |
| Division name | Department of anesthesiology and critical care |
| Address | 83 Kasuga-cho Matsuyama-city, Ehime 790-0024 |
| TEL | 089-947-1111 |
| ytaketa@juntendo.ac.jp | |
| Public contact | |
| Name of contact person | Yasuko Taketa |
| Organization | Ehime Prefectural Central Hospital |
| Division name | Department of anesthesiology and critical care |
| Address | 83 Kasuga-cho Matsuyama-city, Ehime 790-0024 |
| TEL | +81-89-947-1111 |
| Homepage URL | |
| ytaketa@juntendo.ac.jp | |
| Sponsor | |
| Institute | Ehime Prefectural Central Hospital |
| Institute | |
| Department | |
| Sponsor means an organization that is responsible for plan, deployment and report of the research including funding management. It doesn't mean funding agency". Therefore, all clinical trial should have the one. |
| Funding Source | |
| Organization | none |
| Organization | |
| Division | |
| Category of Funding Organization | Other |
| Nationality of Funding Organization | |
| Other related organizations | |
| Co-sponsor | |
| Name of secondary funder(s) | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Progress | |||||||
| Recruitment status | Completed | ||||||
| Date of protocol fixation |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date | |||||||
| Date of closure to data entry | |||||||
| Date trial data considered complete | |||||||
| Date analysis concluded | |||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Published |
| URL releasing results | |
| Results | |
| Other related information | |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000017765 |